Coherus BioSciences, Inc.·4

Aug 8, 4:05 PM ET

Watler Peter K. 4

4 · Coherus BioSciences, Inc. · Filed Aug 8, 2017

Insider Transaction Report

Form 4
Period: 2017-08-06
Watler Peter K.
Chief Technical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-08-06+67,00067,000 total
    Exercise: $12.70Exp: 2027-08-06Common Stock (67,000 underlying)
Footnotes (1)
  • [F1]The underlying shares subject to the option vest and become exercisable as to (i) fifty percent (50%) of the total number of shares subject to the option after one year measured from August 1, 2017 (the "Vesting Commencement Date"), (ii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the eighteen (18) month anniversary of the Vesting Commencement Date and (iii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the two year anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION